X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare AANJANEYA LIFECARE with Cipla - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

DR. DATSONS LABS vs CIPLA - Comparison Results

CIPLA 
   Change

Cipla is one of the largest pharma companies in the domestic market and has presence in formulations and bulk drugs manufacturing. All the bulk drug manufacturing facilities of the company have been approved by various authorities including the US FD... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    DR. DATSONS LABS CIPLA DR. DATSONS LABS/
CIPLA
 
P/E (TTM) x -10.9 44.7 - View Chart
P/BV x 0.2 3.7 4.4% View Chart
Dividend Yield % 0.0 0.3 -  

Financials

 DR. DATSONS LABS   CIPLA
EQUITY SHARE DATA
    DR. DATSONS LABS
Mar-14
CIPLA
Mar-17
DR. DATSONS LABS/
CIPLA
5-Yr Chart
Click to enlarge
High Rs126622 20.2%   
Low Rs31458 6.7%   
Sales per share (Unadj.) Rs133.0181.9 73.1%  
Earnings per share (Unadj.) Rs0.212.9 1.2%  
Cash flow per share (Unadj.) Rs6.629.3 22.5%  
Dividends per share (Unadj.) Rs02.00 0.0%  
Dividend yield (eoy) %00.4 0.0%  
Book value per share (Unadj.) Rs128.8155.7 82.7%  
Shares outstanding (eoy) m31.66804.51 3.9%   
Bonus/Rights/Conversions FCCBESOP-  
Price / Sales ratio x0.63.0 19.8%   
Avg P/E ratio x516.142.0 1,229.9%  
P/CF ratio (eoy) x11.818.4 64.3%  
Price / Book Value ratio x0.63.5 17.5%  
Dividend payout %015.5 0.0%   
Avg Mkt Cap Rs m2,477434,516 0.6%   
No. of employees `000NA23.0 0.0%   
Total wages/salary Rs m5626,338 0.2%   
Avg. sales/employee Rs ThNM6,349.1-  
Avg. wages/employee Rs ThNM1,143.0-  
Avg. net profit/employee Rs ThNM449.3-  
INCOME DATA
Net Sales Rs m4,211146,302 2.9%  
Other income Rs m792,287 3.4%   
Total revenues Rs m4,289148,589 2.9%   
Gross profit Rs m56924,758 2.3%  
Depreciation Rs m20413,229 1.5%   
Interest Rs m4301,594 27.0%   
Profit before tax Rs m1312,222 0.1%   
Minority Interest Rs m00-   
Prior Period Items Rs m-2-70 2.6%   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m61,798 0.3%   
Profit after tax Rs m510,354 0.0%  
Gross profit margin %13.516.9 79.8%  
Effective tax rate %48.014.7 326.6%   
Net profit margin %0.17.1 1.6%  
BALANCE SHEET DATA
Current assets Rs m6,85287,370 7.8%   
Current liabilities Rs m6,71133,081 20.3%   
Net working cap to sales %3.337.1 9.0%  
Current ratio x1.02.6 38.7%  
Inventory Days Days16187 185.0%  
Debtors Days Days31862 511.1%  
Net fixed assets Rs m3,673111,567 3.3%   
Share capital Rs m3171,609 19.7%   
"Free" reserves Rs m3,761123,645 3.0%   
Net worth Rs m4,078125,254 3.3%   
Long term debt Rs m1,67136,454 4.6%   
Total assets Rs m12,633209,532 6.0%  
Interest coverage x1.08.7 11.9%   
Debt to equity ratio x0.40.3 140.8%  
Sales to assets ratio x0.30.7 47.7%   
Return on assets %3.45.7 60.4%  
Return on equity %0.18.3 1.4%  
Return on capital %7.78.5 90.3%  
Exports to sales %22.934.2 66.9%   
Imports to sales %14.38.3 171.4%   
Exports (fob) Rs m96450,050 1.9%   
Imports (cif) Rs m60212,203 4.9%   
Fx inflow Rs m96451,066 1.9%   
Fx outflow Rs m60717,678 3.4%   
Net fx Rs m35733,388 1.1%   
CASH FLOW
From Operations Rs m1,34523,824 5.6%  
From Investments Rs m-2,256-13,127 17.2%  
From Financial Activity Rs m-1,200-13,239 9.1%  
Net Cashflow Rs m-2,111-2,478 85.2%  

Share Holding

Indian Promoters % 4.5 16.0 28.3%  
Foreign collaborators % 0.0 20.8 -  
Indian inst/Mut Fund % 0.0 12.2 -  
FIIs % 1.4 23.7 5.7%  
ADR/GDR % 0.0 1.1 -  
Free float % 94.1 26.2 359.2%  
Shareholders   20,807 161,166 12.9%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare DR. DATSONS LABS With:   SHASUN PHARMA  DR. REDDYS LAB  ABBOTT INDIA  UNICHEM LAB  MERCK LTD  

Compare DR. DATSONS LABS With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Finishes on a Flat Note; Coal India Stock Rallies 4.2%(Closing)

Indian share markets finished some selling pressure in the final hour of trade to finish flat amid weak European markets.

Related Views on News

Cipla: Operating Margins Improve (Quarterly Results Update - Detailed)

Mar 8, 2017

Cipla has announced its results for the December quarter (1QFY17) results. The company has reported a decline of 6.4% YoY in sales while profits were down by 43.7% YoY.

Cipla: Weak Quarter, Positive Triggers Ahead (Quarterly Results Update - Detailed)

Sep 19, 2016

Cipla has announced its results for the June quarter (1QFY17) results. The company has reported a decline of 6.4% YoY in sales while profits were down by 43.7% YoY.

Securities & Intelligence Services Ltd. (IPO)

Jul 31, 2017

Should you subscribe to the IPO of Securities & Intelligence Services Ltd?

Why Super Investors are Underperforming in This Market (The 5 Minute Wrapup)

Jul 8, 2017

If Super Investors can wait for the right pitch, so can you.

Tejas Networks Ltd. (IPO)

Jun 14, 2017

Should you subscribe to the IPO of Tejas Networks Ltd?

More Views on News

Most Popular

Demonetisation Barely Made Any Difference to Tax Collections(Vivek Kaul's Diary)

Aug 7, 2017

The data tells us quite a different story from the one the government is trying to project.

Proxy Plays: A Smart Way to Bet on 'Off Limits' Companies(The 5 Minute Wrapup)

Aug 4, 2017

The small-cap space is full of small players that are clear proxies to great growth stories and Indian megatrends.

Should You Invest In Bharat-22 ETF? Know Here...(Outside View)

Aug 8, 2017

Bharat-22 is one of the most diverse ETFs offered so far by the Government. Know here if you should invest...

Signs of Life in the India VIX(Daily Profit Hunter)

Aug 12, 2017

The India VIX is up 36% in the last week. Fear has gone up but is still low by historical standards.

7 Financial Gifts For Your Sister This Raksha Bandhan(Outside View)

Aug 7, 2017

Raksha Bandhan signifies the brother-sister bond. Here are 7 thoughtful financial gifts for sisters...

More

Become A Smarter Investor In
Just 5 Minutes

Multibagger Stocks Guide 2017
Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

DR. DATSONS LABS SHARE PRICE


May 21, 2015 (Close)

TRACK DR. DATSONS LABS

  • Track your investment in DR. DATSONS LABS with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON DR. DATSONS LABS

DR. DATSONS LABS - ORCHID PHARMA LTD COMPARISON

COMPARE DR. DATSONS LABS WITH

MARKET STATS